Soffer Gad 4
4 · Atara Biotherapeutics, Inc. · Filed Feb 20, 2018
Insider Transaction Report
Form 4
Soffer Gad
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2018-02-15+2,764→ 268,344 total - Exercise/Conversion
Restricted Stock Units
2018-02-15−2,764→ 0 total→ Common Stock (2,764 underlying) - Tax Payment
Common Stock
2018-02-15$47.05/sh−1,456$68,505→ 266,888 total
Footnotes (5)
- [F1]Shares issued upon settlement of vested restricted stock units ("RSUs").
- [F2]Shares withheld to cover tax obligation from settlement of vested restricted stock units.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock or a cash settlement.
- [F4]Fully vested.
- [F5]The earlier of (i) January 10, 2021 or (ii) the recipient's termination date.